In the June 17 iWiMS COVID-19 update Dr Ruth Dobson (QMUL, UK) asks the question: What role does VitaminD play in COVID-19 outcomes? Dr Kate Fitzgerald (JHU, USA) presents data from a collaborative effort with Cemcat looking at predictors of COVID-19 infection in people with MS. Louise Rath, clinical nurse consultant at Aflred Health (AU) describes their experiences of rapid infusion regimens for natalizumab and ocrelizumab in the time of COVID-19.
Video
Please note, these videos are intended for a medical and scientific audience for educational purposes. All Registries collecting data on COVID-19 patients have been approved by research ethics committees/IRBs. Data are anonymised, no personal patient information is presented.